Company
LON:IMM
ImmuPharma PLC is a biopharmaceutical company that specializes in the usage and development of biopolymers, specifically peptides. The company is dedicated to developing an innovative portfolio of peptide-based therapeutic drugs with a focus on autoimmunity/inflammation and anti-infectives.
306 stories · page 9 of 16
Investments and investor services
The FTSE 100 has clawed back all of this morning's losses and some, while the ECB has unveiled plans to end its quantitative easing programme in December
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A look at today's major risers and fallers in London, including Advanced Oncotherapy, Tekcapital, IDOX, RedstoneConnect, Dixons Carphone and Renold
ImmuPharma chairman Tim McCarthy said: "We continue to believe Lupuzor has the potential to bring a much needed treatment to Lupus sufferers around the world"
In the current markets, the pound fell 0.49% against the US dollar at 1.1472..
The pair said the debate around the company's flagship drug is far more 'nuanced' than the top-line data might suggest, which explains why potential licensing partners are keen to continue talking to management
Archive
A look back at some of the more interesting from the junior market this week
A look at some of the highlight movers, up and down, in London
“We need to see more data,” said Northland Capital's Vadim Alexandre. “There is a major unmet medical"
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the top news-driven risers in London at 3.45pm ...
The company revealed there had been "expressions of interest" in its lupus programme which it will explore
FTSE 100 closed higher, as did it mid-cap cousin, FTSE 250
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Wednesday
The UK blue-chip index finished over 44 points higher at 7,044, but big miners tempered gains
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Friday
